US Flu VE Network
The U.S. Flu Vaccine Effectiveness (VE) network is designed to provide estimates of clinical effectiveness of licensed vaccines by age group and by influenza type and subtype.
The network consists of five study sites spread across the United States, including sites in the following states:
- Pennsylvania; and
Enrollment in the annual study to measure VE begins after laboratory-confirmed influenza cases are reported in local surveillance for two consecutive weeks and continues for the rest of flu season.
The study uses a test-negative design which compares vaccination rates among influenza “cases” and “controls.” The test-negative design has outpatients with a new cough who test positive for influenza as cases, and outpatients with a new cough who test negative for influenza as controls. See Study Design Factors for more information.
Vaccination status is defined as receipt of at least one dose of the current season’s vaccine according to medical records, immunization registries, and or/self-report.
Patients are eligible if they are older than 6 months of age (thus being eligible to receive influenza vaccination) and they have reported acute respiratory illness with cough within seven days.
Eligible patients complete an enrollment interview and answer basic questions regarding their influenza vaccination status, age, underlying health conditions, and other characteristics. Influenza vaccination status is later confirmed by reviewing records and immunization databases.
Following enrollment, a respiratory specimen is collected and tested for influenza by the CDC real-time reverse transcription polymerase chain reaction (RT-PCR) assay. Influenza-positive samples are then typed and subtyped.
Estimates are adjusted for study site, age, sex, self-rated general health status, race/Hispanic ethnicity, interval from onset to enrollment, and calendar time.
For more information about how CDC’s VE studies are conducted and how to interpret results, see Flu Vaccine Effectiveness: Questions and Answers for Health Professionals. See Seasonal Influenza Vaccine Effectiveness, 2004-2018 for a table that shows the overall adjusted VE and related reference for each season starting in 2004-05.